内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Swartz Robin. Insider active across 1 company, notably Voyager Therapeutics, Inc.. Cumulatively, 19 disclosures have been published. Breakdown: 0 buy · 16 sells. Total volume traded: €409k. History available since 21 March 2022. The latest transaction was disclosed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Swartz Robin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
6,458 股@ US$3.775.0% 占其流量Common StockSEC:0001104659-26-020183:0
3,882 股@ US$3.442.8% 占其流量Common StockSEC:0001104659-26-018131:0
4,569 股@ US$3.853.6% 占其流量Common StockSEC:0001104659-26-013416:0
45,000 股0Common StockSEC:0001104659-26-012675:0
3,894 股@ US$4.254.4% 占其流量Common StockSEC:0001104659-25-016516:0
6,950 股@ US$4.458.3% 占其流量Common StockSEC:0001104659-25-012198:0
3,087 股@ US$5.094.2% 占其流量Common StockSEC:0001104659-25-003773:0
6,500 股@ US$5.659.7% 占其流量Common StockSEC:0001104659-24-131725:0
1,357 股@ US$9.883.4% 占其流量Common StockSEC:0001104659-24-043107:0
3,966 股@ US$7.457.5% 占其流量Common StockSEC:0001104659-24-026562:0
50,000 股0Common StockSEC:0001104659-24-024989:0
2,543 股@ US$7.154.6% 占其流量Common StockSEC:0001104659-24-005247:0
1,259 股@ US$7.832.5% 占其流量Common StockSEC:0001104659-23-042228:0
3,654 股@ US$7.767.3% 占其流量Common StockSEC:0001104659-23-035640:0
15,373 股@ US$8.2032.4% 占其流量Common StockSEC:0001104659-23-033928:0
40,000 股0Common StockSEC:0001104659-23-024419:0
1,396 股@ US$9.573.4% 占其流量Common StockSEC:0001104659-23-005049:0
1,527 股@ US$8.252.8% 占其流量Common StockSEC:0001104659-22-043246:0
4,362 股@ US$8.298.0% 占其流量Common StockSEC:0001104659-22-037154:0
About Swartz Robin
Swartz Robin is a declarant linked to Voyager Therapeutics, Inc. (XNAS) as COO & CBO. Across 19 filings in total, the 19 sampled filings cover the period from 2022-03-23 to 2026-02-26 and show 0 in buys and 409240 in sells, with Cession as the modal transaction nature.